Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 4Prostatic Neoplasms 3Muscle Weakness 2Motor Activity 2Sedentary Behavior 1Sarcopenia 1Muscular Atrophy 1Head and Neck Neoplasms 1Fatigue 1Cachexia 1Body Weight Changes 1Anorexia 1

Interventions

Early Intervention, Educational 4Counseling 4Psychiatric Rehabilitation 3Exercise 3Radiotherapy 2Megestrol Acetate 2Diet 2Cyproheptadine 2Yoga 1Watchful Waiting 1Vegetables 1Standard of Care 1Professional Autonomy 1Oxandrolone 1Observation 1Nutritional Status 1Nutrition Therapy 1Motivational Interviewing 1Methods 1Mental Status and Dementia Tests 1Magnetic Resonance Spectroscopy 1Immunoenzyme Techniques 1Fruit 1Exercise Therapy 1Diet, Fat-Restricted 1Creatine 1Control Groups 1Calcium 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Body Weight Changes × Creatine × Clear all
NCT00081250 2020-04-29

Creatine in Treating Patients With Cancer-Associated Weight Loss

Alliance for Clinical Trials in Oncology

Phase 3 Completed
300 enrolled

Anorexia, Body Weight Changes, Cachexia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡